Colrain Capital LLC Has $9.89 Million Stake in CVS Health Corporation $CVS

Colrain Capital LLC raised its position in shares of CVS Health Corporation (NYSE:CVS) by 27.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 131,205 shares of the pharmacy operator’s stock after purchasing an additional 27,863 shares during the period. CVS Health comprises 5.6% of Colrain Capital LLC’s portfolio, making the stock its 6th biggest position. Colrain Capital LLC’s holdings in CVS Health were worth $9,892,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CVS. Avion Wealth grew its holdings in CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. raised its holdings in shares of CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 142 shares in the last quarter. Corundum Trust Company INC purchased a new stake in shares of CVS Health in the 3rd quarter worth approximately $29,000. Front Row Advisors LLC increased its holdings in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 371 shares during the period. Finally, Twin Peaks Wealth Advisors LLC bought a new position in CVS Health in the second quarter worth approximately $36,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE CVS opened at $78.45 on Tuesday. The company has a 50 day simple moving average of $78.68 and a two-hundred day simple moving average of $76.45. The stock has a market cap of $99.80 billion, a price-to-earnings ratio of 56.85, a PEG ratio of 0.82 and a beta of 0.50. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a 12 month low of $58.35 and a 12 month high of $85.15.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. During the same period last year, the company earned $1.19 earnings per share. CVS Health’s revenue for the quarter was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $91.00 price objective on shares of CVS Health in a research report on Tuesday, January 6th. Raymond James Financial lifted their target price on CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Wells Fargo & Company cut their price objective on shares of CVS Health from $103.00 to $102.00 and set an “overweight” rating on the stock in a research report on Thursday, November 13th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average price target of $94.91.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.